About Genfit S.A. (adapted from Genfit S.A. prospectus):
Their ordinary shares are listed on Euronext Paris under the symbol NFT. On March 8, 2019, the last reported sale price of their ordinary shares on Euronext Paris was 23.42 per ordinary share, equivalent to a price of $26.33 per ADS, assuming an exchange rate of 0.8894 per U.S. dollar, the exchange rate on December 31, 2018 They are a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions targeting metabolic and liver-related diseases where there is considerable unmet medical need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.